SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 6, 2026

UTHR

UNITED THERAPEUTICS Corp
MIXED
Impact 6/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $490K total
Actionable Insight ◆ Mixed

Insider sales are quantitatively insignificant relative to market cap (0.03%) and partly tied to option exercises/vesting, but the cluster's proximity to a revenue-miss earnings release warrants monitoring for additional sales in coming weeks. Watch for any 8-K filings regarding Tyvaso competitive dynamics or ralinepag NDA updates.

DirectionMixed
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$538.84
T+0 close · Aug 6, 2026 · via day close
Latest settled
+11.11%
T+60 · $598.72
Vs SPY
+13.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 7 $538.84entry
  2. T+1 · 3mo ago −1.70%α −1.67% · $529.66
  3. T+5 · 3mo ago −7.26%α −7.66% · $499.73
  4. T+20 · 2mo ago −9.51%α −9.11% · $487.61
  5. T+60 · 15d ago +11.11%α +13.38% · $598.72
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

United Therapeutics CEO Martine Rothblatt and EVP Paul Mahon collectively sold ~$490K in open-market shares within two days of the company's Q2 2026 earnings release, which showed a 2% YoY revenue miss ($783.3M vs. $804.6M consensus) but an EPS beat ($7.27 vs. $6.86). The sales follow option exercises and represent a small fraction of market cap, but the timing, right after a mixed earnings report with declining Tyvaso sales, raises watchfulness.

Key Financial Metrics

Direction
selling
Total Value
$6.8M
Insiders
2

Key Facts

  • CEO Rothblatt sold 4,895 open-market shares on Aug 5, 2026, for ~$2.5M (including sales after option exercises).
  • EVP Mahon sold 8,300 open-market shares on Aug 6, 2026, for ~$4.3M (including sales after option exercises).
  • Total open-market sales in cluster: ~$6.8M, representing 0.03% of $22.6B market cap, trivial proportionally.
  • Q2 2026 revenue of $783.3M missed consensus by ~2.7% (down 2% YoY); EPS of $7.27 beat by 5.9%.
  • Tyvaso Nebulized sales fell 18% YoY, partially offset by Tyvaso DPI growth.
  • Insider cluster closed within 2 days of earnings, triggering AMPLIFIER cross-filing actuarial verdict (cluster-earnings-context + cluster-insider-trades).

Financial Impact

Total open-market insider sales of ~$6.8M (0.03% of market cap) are trivial in size; primary economic event is the mixed Q2 earnings with revenue miss but EPS beat.

revenueepsinsider sales volume

Risk Factors

  • Continued erosion of Tyvaso Nebulized sales could pressure top-line growth; Tyvaso DPI must accelerate to offset.
  • Insiders selling after earnings may signal lack of confidence in near-term pipeline catalysts (ralinepag, IPF filing).

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1786082523840

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (11h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 7, 2026